3-Bromopyruvate (BrPA), a specific HK-II inhibitor, significantly reduces the arthritis and the histological scores in the SKG mouse model (a genetic model with many RA features) while significantly increasing the number of regulatory T cells (Treg). Here, HK2 is linked to Arthritis.